EUGENE, OREGON, US, 22 January 2015 – Electrical Geodesics, Inc. (“EGI” or the “Company”), a leading neurodiagnostic medical technology company, today announces it has entered into a two year agreement to supply GES 400 systems for use with ElMindA’s Brain Network Activation (BNA™) platform.
ElMindA is a US and Israel-based company that is engaged in the development, marketing, and distribution of the BNA™ platform, an analysis system that received FDA clearance in 2014 for the assessment of brain function in 14 to 24-years old. Combining EGI’s non-invasive, multi-channel EEG technology with ElMindA’s signal processing and analysis algorithms, BNA™ measures patterns of brain networks activated during specific brain processes and delivers both quantitative and qualitative insights into brain function and dysfunction. Using its proprietary database with more than 8,000 datasets, BNA™ can be used by physicians to potentially help identify and manage neurological disorders.
Don Tucker, CEO of EGI, commented: “We have worked with ElMindA over a number of years and are pleased that their research efforts have led to the BNA™ system receiving FDA clearance. ElMindA recognizes the need for the precision dense array EEG provides to enable objective assessment of brain disorders and injuries. We believe that by working together, we can bring both our technologies into wider clinical use and drive revenues for both companies.”
Under the agreement, EGI agrees to supply and support ElMindA’s customers purchasing the BNA™ analysis system with its leading GES 400 dense array EEG systems on pre-determined terms.
“EGI delivers the quality of dEEG data required to support the BNA™ platform,” said Ronen Gadot, CEO of ElMindA. “We are pleased to collaborate with a partner that offers cutting edge, reliable technology, allowing physicians to acquire the level of data needed to deliver BNA™ test reports in a timely and cost-effective manner. The importance of this technology has been recognized by the Chief Science Officer of Israel, who has granted funding to further develop the BNA™ system for both diagnostic and therapeutic applications.”
For more information contact:
EGI
UK: Christine Soden, CFO
+44 (0) 7710 484199
Peel Hunt LLP (NOMAD and Broker)
+44 (0) 20 7418 8900
James Steel, Clare Terlouw
FTI Consulting (PR Advisors)
+44 (0) 20 3727 1000
Simon Conway, Mo Noonan
Notes to Editors
Electrical Geodesics, Inc. in Summary
Founded in 1992, EGI designs, develops and commercialises a range of non-invasive neurodiagnostic and neuromodulation products used to monitor, interpret and modulate brain activity, based on its proprietary dense array electroencephalography (“dEEG”) platform technology. The Company’s technology uses up to 256 sensors, providing much higher resolution brain activity data compared to conventional 8 or 16 channel EEG and is used in medical, clinical and research settings in a diverse range of applications including important areas such as the diagnosis and monitoring of epilepsy, neurosurgical planning, sleep assessment, and many others.
EGI’s dEEG systems, available in the GES 300 and now the GES 400 lines, capitalise on the Company’s unique Hydrocel Geodesic Sensor Net which allows faster, easier, and more convenient placement of many EEG sensors in an even distribution over the entire scalp, providing more accurate and precise diagnosis and measurement. EGI’s technology is now widely used in neuroscience research laboratories and is becoming more commonly used in clinics, care centers, and hospitals around the world. Data is measured and visualised using EGI’s proprietary amplifier technology and software, providing a complete, advanced, high-resolution EEG platform. The Company’s products are compatible with multiple diagnostic and imaging technologies, including magnetic resonance (MR) imaging, functional MRI (fMRI), and magneto-encephalography (MEG).
See our website www.egi.com
ElMindA Ltd.
ElMindA was founded in 2006 to address an unmet need for objectively assessing brain health and brain-related disorders over the course of an individual’s lifetime. ElMindA translates state-of-the-art neuroscience via advanced algorithmic science into clinically meaningful Brain Network Activation (BNA™) maps. ElMindA is a preferred partner of industry-leading organizations based on the rigor of its science and technology development
Help employers find you! Check out all the jobs and post your resume.
